Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 205, Issue 10, Pages 2199-2206Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20080579
Keywords
-
Categories
Funding
- Human Frontiers Science Program Organization
- Ministerio de Educacion y Ciencia [SAF2007-63130]
- Comunidad Autonoma de Madrid (DIFHEMAT-CM)
- European Research Council [BCLYM-207844]
Ask authors/readers for more resources
Activated B cells reshape their primary antibody repertoire after antigen encounter by two molecular mechanisms: somatic hypermutation (SHM) and class switch recombination (CSR). SHM and CSR are initiated by activation-induced cytidine deaminase (AID) through the deamination of cytosine residues on the immunoglobulin loci, which leads to the generation of DNA mutations or double-strand break intermediates. As a bystander effect, endogenous AID levels can also promote the generation of chromosome translocations, suggesting that the fine tuning of AID expression may be critical to restrict B cell lymphomagenesis. To determine whether microRNAs ( miRNAs) play a role in the regulation of AID expression, we performed a functional screening of an miRNA library and identified miRNAs that regulate CSR. One such miRNA, miR-181b, impairs CSR when expressed in activated B cells, and results in the down-regulation of AID mRNA and protein levels. We found that the AID 3' untranslated region contains multiple putative binding sequences for miR-181b and that these sequences can be directly targeted by miR-181b. Overall, our results provide evidence for a new regulatory mechanism that restricts AID activity and can therefore be relevant to prevent B cell malignant transformation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available